Patents by Inventor Javier Pavon Moron
Javier Pavon Moron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220313620Abstract: This invention relates to the delivery of a composition, preferably a pharmaceutical composition, comprising D-pinitol, D-Chiro inositol or myo-inositol or any pharmaceutically acceptable salt thereof, for use in the treatment or prevention of disorders, diseases or conditions responsive to the stimulation of the ghrelin receptor in a subject in need thereof.Type: ApplicationFiled: September 9, 2020Publication date: October 6, 2022Inventors: Fernando RODRIGUEZ DE FONSECA, Juan Antonio NAVARRO GALERA, Elena BAIXERAS LLANO, Juan Manuel DECARA DEL OLMO, Dina MEDINA VERA, Antonio Jesús LÓPEZ GAMBERO, Juan SUAREZ PEREZ, Carlos SANJUAN MERINO, Cristina ROSELL DEL VALLE, Francisco Javier PAVÓN MORÓN
-
Patent number: 11058650Abstract: The invention relates to the use of fatty acid amides with phenylalkylamines and of a pharmaceutical composition comprising at least one of these compounds in the prevention and/or treatment of fatty liver or a pathological condition or disease caused by fatty liver, either alcoholic or non-alcoholic, and, in particular, for the prevention and/or treatment of the alcoholic steatohepatitis or non-alcoholic steatohepatitis (NASH).Type: GrantFiled: November 24, 2015Date of Patent: July 13, 2021Assignees: FUNDACIÓN PÚBLICA ANDALUZA PARA LA INVESTIGACIÓN DE MÁLAGA EN BIOMEDICINA Y SALUD (FIMABIS), CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC), FUNDACIÓ INSTITUT MAR DTNVESTIGACIONS MÈDIOUESInventors: Fernando Rodríguez De Fonseca, Francisco Javier Pavón Morón, Juan Manuel Decara Del Olmo, Antonia Serrano Criado, Jesús Joglar Tamargo, Pedro Clapés Saborit, Rafael De La Torre Fornell, Magí Ferre Albaladejo, María Isabel Covas Planells, Montserrat Fito Colomer, Bruno Almeida Cotrim
-
Publication number: 20180193293Abstract: The invention relates to the use of fatty acid amides with phenylalkylamines and of a pharmaceutical composition comprising at least one of these compounds in the prevention and/or treatment of fatty liver or a pathological condition or disease caused by fatty liver, either alcoholic or non-alcoholic, and, in particular, for the prevention and/or treatment of the alcoholic steatohepatitis or non-alcoholic steatohepatitis (NASH).Type: ApplicationFiled: November 24, 2015Publication date: July 12, 2018Inventors: Fernando RODRÍGUEZ DE FONSECA, Francisco Javier PAVÓN MORÓN, Juan Manuel DECARA DEL OLMO, Antonia SERRANO CRIADO, Jesús JOGLAR TAMARGO, Pedro CLAPÉS SABORIT, Rafael DE LA TORRE FORNELL, Magí FERRÉ ALBALADEJO, María Isabel COVAS PLANELLS, Montserrat FITO COLOMER, Bruno ALMEIDA COTRIM
-
Publication number: 20160152579Abstract: The present invention relates to a family of differently substituted oxazolidinones and to the pharmaceutically acceptable salts, esters, prodrugs, tautomers, solvates and hydrates thereof, which show affinity for the alpha and gamma subtypes of the peroxisome proliferator-activated receptors (PPAR) and which, therefore, modulate the actions regulated by said receptors, such as inducing satiety, controlling ingestion and modulating metabolic effects, and thus are useful for the administration thereof as a pharmacological tool and as drugs for the treatment and/or prevention of metabolic diseases and cardiovascular diseases.Type: ApplicationFiled: July 11, 2014Publication date: June 2, 2016Applicants: Servicio Andaluz de Salud, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS), Consejo Superior de Investigaciones Científicas (CSIC)Inventors: Ruth Pérez Fernández, María Nieves Fresno López, José Elguero Bertolini, Pilar Goya Laza, Ana Belén Torres Zaguirre, Fernando Rodíguez De Fonseca, Francisco Javier Pavón Morón, Manuel Macías González, Miguel Romero Cuevas
-
Patent number: 8188312Abstract: The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use.Type: GrantFiled: January 26, 2007Date of Patent: May 29, 2012Assignees: Fundacion Imabis. Instituto Mediterraneo para el Avance de la Biotecnologia y la Investigacion Sanitaria, Consejo Superior de Investigaciones CientificasInventors: Fernando Antonio Rodriguez de Fonseca, Manuel Macias Gonzalez, Javier Pavon Moron, María Pilar Goya-Laza, Juan Antonio Paez Prosper, Carolina Cano Ramos
-
Publication number: 20100179224Abstract: The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R1 and R2 may be the same or different, when R1 and R2 are different, R1 is a linear C12-C20 alkyl group or a linear C12-C20 alkenyl group comprising 1, 2, 3 or 4 double bonds; and R2 is a hydrogen atom or a C1-C4 alkyl group, or when R1 and R2 are the same, R1 and R2 are a linear C14-C20 alkyl group or a linear C14-C20 alkenyl group with 1, 2, 3 or 4 double bonds, and pharmaceutically acceptable salts, solvates and hydrates thereof, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulphamide derivatives are also useful for cosmetic use for reducing subcutaneous fat.Type: ApplicationFiled: January 26, 2007Publication date: July 15, 2010Applicants: Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia y La Investigacion Sanitaria, Consejo Superior De Investigaciones CientificasInventors: Fernando Antonio RODRIGUEZ DE FONSECA, Manuel MACIAS GONZALEZ, Javier PAVON MORON, María Pilar GOYA-LAZA, Juan Antonio PAEZ PROSPER, Carolina CANO RAMOS
-
Publication number: 20100048712Abstract: The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R1 and R2 may be the same or different, when R1 and R2 are different, R1 is a linear C12-C20 alkyl group or a linear C12-C20 alkenyl group comprising 1, 2, 3 or 4 double bonds; and R2 is a hydrogen atom or a C1-C4 alkyl group, or when R1 and R2 are the same, R1 and R2 are a linear C14-C20 alkyl group or a linear C14-C20 alkenyl group with 1, 2, 3 or 4 double bonds, and pharmaceutically acceptable salts, solvates and hydrates thereof, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulphamide derivatives are also useful for cosmetic use for reducing subcutaneous fat.Type: ApplicationFiled: January 26, 2007Publication date: February 25, 2010Applicants: Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia y La Investigacion Sanitaria, Consejo Superior De Investigaciones CientificasInventors: Fernando Antonio RODRIGUEZ DE FONSECA, Manuel MACIAS GONZALEZ, Javier PAVON MORON, María Pilar GOYA-LAZA, Juan Antonio PAEZ PROSPER, Carolina CANO RAMOS
-
Publication number: 20090221710Abstract: The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use.Type: ApplicationFiled: January 26, 2007Publication date: September 3, 2009Inventors: Fernando Antonio Rodriguez De Fonseca, Manuel Macias Gonzalez, Javier Pavon Moron, Maria Pilar Goya-Laza, Juan Antonio Paez Prosper, Carolina Cano Ramos